AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

QIST Collaborative - Arthroplasty Research Cohort (ARC) Study

Recruitingn/aAges 18 Years - anyAllNorthumbria Healthcare NHS Foundation Trust
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The ARC Study is a national observational cohort study to investigate patient reported and clinical outcomes after hip and knee replacements. The study has the following objectives: 1. To evaluate outcomes following hip and knee replacements. 2. To determine risk factors for adverse outcomes in primary hip and knee replacements. 3. To identify targets for future research and intervention in patients undergoing primary hip and knee replacements 4. To provide a resource from which to identify potential participants for future clinical trials, and to use data collected in the ARC Study as comparison or control data for trial participants who have been randomised to receive one or more interventions. Participants are recruited and consented online. Patients are invited to participate by collaborating surgical teams nationally in outpatient clinics at the time of being added to a waiting li

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: Participants must meet all of the inclusion criteria: 1. UK Resident 2. Able to read and understand documentation and questionnaires in English language 3. Undergoing elective primary hip or knee arthroplasty (THR, TKR or UKR) 4. Age 18 years or over 5. Provides the necessary consents relating to data collection and use of study data, data linkage, future research and invitation to involvement in future trials Exclusion Criteria: Provided a participant meets all of the inclusion criteria, there are no exclusion criteria for the cohort study.
๐Ÿ’Š

What it tests

  • Hip/Knee Replacement
๐Ÿ“

Where

1 site
Northumbria Healthcare NHS Foundation Trust
Ashington, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy